Heather Sevinsky

Summary

Affiliation: Bristol-Myers Squibb
Country: USA

Publications

  1. ncbi The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women
    Heather Sevinsky
    Research and Development, Bristol Myers Squibb, Princeton, NJ, USA
    Antivir Ther 16:149-56. 2011
  2. ncbi Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study
    Li Zhu
    Bristol Myers Squibb, Research and Development, Princeton, NJ, USA
    J Antimicrob Chemother 67:465-8. 2012

Collaborators

Detail Information

Publications2

  1. ncbi The effect of efavirenz on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy HIV-negative women
    Heather Sevinsky
    Research and Development, Bristol Myers Squibb, Princeton, NJ, USA
    Antivir Ther 16:149-56. 2011
    ..Women of childbearing age represent a growing proportion of people living with HIV. Preventing pregnancy is important in HIV-infected women receiving efavirenz as part of their antiretroviral therapy...
  2. ncbi Pharmacokinetics and inhibitory quotient of atazanavir/ritonavir versus lopinavir/ritonavir in HIV-infected, treatment-naive patients who participated in the CASTLE Study
    Li Zhu
    Bristol Myers Squibb, Research and Development, Princeton, NJ, USA
    J Antimicrob Chemother 67:465-8. 2012
    ..To characterize the pharmacokinetics and inhibitory quotient (IQ) of atazanavir/ritonavir- and lopinavir/ritonavir-based regimens in HIV-infected, treatment-naive patients...